Novel Cell Delivery Method for Brain Tumor Therapy
Novel Cell Delivery Method for Brain Tumor Therapy
批准号:
8637349
负责人:
Behnam Badie
金额:
$18.4万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2016-04-30
关键词:
Alternative TherapiesAnimal ExperimentsAnimalsAntineoplastic AgentsAspirate substanceBlood - brain barrier anatomyBlood coagulationBrainBrain MassBrain NeoplasmsCannulasCattleCauterization - actionCauterizeCell TherapyCellsClinicalClinical TrialsDevelopmentDevice or Instrument DevelopmentDevicesDiseaseDisease ProgressionFamily suidaeFeasibility StudiesFormalinGelatinGenerationsGlioblastomaGliomaGoalsHematomaHemostatic functionHumanImageIn VitroInfusion proceduresInjection of therapeutic agentInjuryLaboratoriesLiverMalignant NeoplasmsMalignant neoplasm of brainMechanicsMethodsMissionModelingNatural Killer CellsNeoplasm MetastasisNeuraxisOperative Surgical ProceduresOrganPatientsPerformancePharmaceutical PreparationsPreparationPublic HealthSafetySolidTechniquesTestingTherapeuticThermal Ablation TherapyTimeTissuesTrephine holeTumor DebulkingTumor TissueViral Vectorcancer therapycraniumdesignfrontal lobeimprovedin vitro testingin vivoinnovationinstrumentmacromoleculememberminimally invasiveneoplastic cellneurosurgerynovelpre-clinicalpreventprototypepublic health relevancetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Even when treated with aggressively with current therapies, most patients with primary malignant brain tumors (glioma) survive less than two years. Although targeted therapies are being developed, the blood-brain barrier prevents large molecules from penetrating the central nervous system and moving to the brain. Because gliomas rarely metastasize, a localized tumor treatment could be sufficient to prevent the disease from progressing. As a result, methods are being developed to allow for the delivery of tumor-specific macromolecules directly into the brain tumors. However, these approaches require infusions of high-volumes of drugs which can be time consuming or impractical in an organ with limited space capacity, such as the brain. Thus, there is a pressing need for improved methods to deliver targeted macromolecules into brain tumors. The goal of this project is to fabricate and evaluate the feasibility of a novel instrument that is capable of creating a cavity within brain tumors using image-guided, minimally invasive techniques. The cavity that is generated by the instrument can then be used as a reservoir to deliver anti-cancer macromolecules or cells directly into the tumor. Using image guidance, the instrument is inserted into the tumor through a small burr hole for central tumor debulking. The unique mechanical features of this instrument will allow it to detach, fragment, cauterize and aspirate the tumor tissue through a small channel. Initial studies using proof-of concept prototypes have demonstrated the mechanical feasibility of this approach. Here, we propose to fabricate prototypes of a pre-clinical grade device, and characterize the performance of this instrument in vitro and in vivo. After completing this project, we expect to generate instrument designs for fabricating clinical- grade prototypes that are suitable for testing in human safety trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
-
批准号:10750788
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2023
-
负责人:Behnam Badie
-
依托单位:
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
-
批准号:10696180
-
项目类别:
-
资助金额:$91.77万
-
财政年份:2021
-
负责人:Behnam Badie
-
依托单位:
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
-
批准号:10306300
-
项目类别:
-
资助金额:$99.91万
-
财政年份:2021
-
负责人:Behnam Badie
-
依托单位:
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
-
批准号:10488199
-
项目类别:
-
资助金额:$92.09万
-
财政年份:2021
-
负责人:Behnam Badie
-
依托单位:
Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma Therapy
-
批准号:8638705
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2013
-
负责人:Behnam Badie
-
依托单位:
Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma Therapy
-
批准号:8726502
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2013
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
-
批准号:8890797
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
-
批准号:8507470
-
项目类别:
-
资助金额:$32.77万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
-
批准号:9312100
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
-
批准号:8329598
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
-
批准号:8707217
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
-
批准号:9899943
-
项目类别:
-
资助金额:$40.76万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
-
批准号:8186387
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2011
-
负责人:Behnam Badie
-
依托单位:
Application of Carbon Nanotubes for Macrophage Activation in Brain Tumor Models
-
批准号:7659710
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2009
-
负责人:Behnam Badie
-
依托单位:
Application of Carbon Nanotubes for Macrophage Activation in Brain Tumor Models
-
批准号:7849933
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2009
-
负责人:Behnam Badie
-
依托单位:
GMP Manufacturing Core
-
批准号:10059200
-
项目类别:
-
资助金额:$17.35万
-
财政年份:1997
-
负责人:Behnam Badie
-
依托单位:
海外基金